Literature DB >> 1322718

The prevalence of types I and II feline coronavirus infections in cats.

T Hohdatsu1, S Okada, Y Ishizuka, H Yamada, H Koyama.   

Abstract

The types of feline coronaviruses that are prevalent throughout Japan were determined by competitive enzyme-linked immunosorbent assay (ELISA) using a monoclonal antibody (MAb) to feline infectious peritonitis virus (FIPV) Type II and neutralizing test using Type II FIPV as challenge virus. A total of 1,079 cat serum samples were tested by indirect fluorescent antibody (IFA) assay for FIPV Type II antigen, all 42 sample from natural cases of FIP, 138 of 647 (21.3%) from cases with some chronic diseases and 57 of 390 (14.6%) from apparently non-diseased cases were positive. Of the 42 cases with FIP, 29 (69%) and 13 (31%) were found to have infection with FIPV Types I and II, respectively. Of the cases with chronic diseases, 111 (80.4%) were shown to have infection with FIPV or FECV Type I, while 14 (10.1%) with FIPV or FECV Type II. All of the 57 apparently non-diseased cases seemed to have been infected with FIPV or FECV Type I. These results indicated that feline coronavirus Type I is more high prevalent in Japan.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322718     DOI: 10.1292/jvms.54.557

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  76 in total

1.  A reverse genetics approach to study feline infectious peritonitis.

Authors:  Gergely Tekes; Danica Spies; Barbara Bank-Wolf; Volker Thiel; Heinz-Jürgen Thiel
Journal:  J Virol       Date:  2012-04-04       Impact factor: 5.103

2.  Feline coronavirus type II strains 79-1683 and 79-1146 originate from a double recombination between feline coronavirus type I and canine coronavirus.

Authors:  A A Herrewegh; I Smeenk; M C Horzinek; P J Rottier; R J de Groot
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Tackling feline infectious peritonitis via reverse genetics.

Authors:  Volker Thiel; Heinz-Jürgen Thiel; Gergely Tekes
Journal:  Bioengineered       Date:  2014-10-30       Impact factor: 3.269

4.  Prevalence and genetic pattern of feline coronaviruses in urban cat populations.

Authors:  I Kiss; S Kecskeméti; J Tanyi; B Klingeborn; S Belák
Journal:  Vet J       Date:  2000-01       Impact factor: 2.688

5.  Molecular characterization of feline infectious peritonitis virus strain DF-2 and studies of the role of ORF3abc in viral cell tropism.

Authors:  Ádám Bálint; Attila Farsang; Zoltán Zádori; Ákos Hornyák; László Dencso; Fernando Almazán; Luis Enjuanes; Sándor Belák
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Feline coronavirus serotypes 1 and 2: seroprevalence and association with disease in Switzerland.

Authors:  Maya Kummrow; Marina L Meli; Michael Haessig; Enikoe Goenczi; Amy Poland; Niels C Pedersen; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

7.  Pathogenic characteristics of persistent feline enteric coronavirus infection in cats.

Authors:  Liesbeth Vogel; Mariken Van der Lubben; Eddie G te Lintelo; Cornelis P J Bekker; Tamara Geerts; Leontine S Schuijff; Guy C M Grinwis; Herman F Egberink; Peter J M Rottier
Journal:  Vet Res       Date:  2010-07-23       Impact factor: 3.683

8.  Genome organization and reverse genetic analysis of a type I feline coronavirus.

Authors:  Gergely Tekes; Regina Hofmann-Lehmann; Iris Stallkamp; Volker Thiel; Heinz-Jürgen Thiel
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 9.  A review of feline infectious peritonitis virus infection: 1963-2008.

Authors:  Niels C Pedersen
Journal:  J Feline Med Surg       Date:  2009-02-28       Impact factor: 2.015

10.  The virus-host interface: Molecular interactions of Alphacoronavirus-1 variants from wild and domestic hosts with mammalian aminopeptidase N.

Authors:  Ximena A Olarte-Castillo; Joana F Dos Remédios; Felix Heeger; Heribert Hofer; Stephan Karl; Alex D Greenwood; Marion L East
Journal:  Mol Ecol       Date:  2021-05-03       Impact factor: 6.185

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.